21.20.Z - Manufacture of medicines and other pharmaceutical products
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.76.Z - Wholesale of other intermediate products
47.73.Z - Dispensing chemist in specialised stores
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
82.99.Z - Other business support service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 13,5 | 13,3 | 13,3 | 0,3 |
Gross profit (loss) | -0 | -0,2 | 0 | 110,7 |
Net profit (loss) | -0 | -0,2 | 0 | 110,7 |
Cash | 0 | 0 | 0 | -85,4 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,4 | 1,8 |
Short time liabilities | 0 | 0 | 0 | -94,4 |
Equity capital | 13,1 | 12,9 | 12,9 | 0,2 |
Working assets | 0 | 0 | 0 | -85,4 |
Operating profit (EBIT) | -0 | -0 | -0 | -26,1 |
% | % | % | p.p. | |
Equity capital to total assets | 97,4 | 96,9 | 96,8 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 28.449918746948242 | 4.466015815734863 | 11.713740348815918 | 7,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane